Literature DB >> 18249054

Mild Smith-Lemli-Opitz syndrome: further delineation of 5 Polish cases and review of the literature.

A Jezela-Stanek1, E Ciara, E M Malunowicz, L Korniszewski, D Piekutowska-Abramczuk, E Popowska, M Krajewska-Walasek.   

Abstract

Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder caused by reduced activity of 7-dehydrocholesterol reductase, resulting in an increased concentrations of 7-dehydrocholesterol and 8-dehydrocholesterol in body fluids and tissues. Phenotypically it is characterized by wide range of abnormalities, from mild to lethal forms what causes difficulties in its clinical diagnostics. To further delineate the physical spectrum of the mild form of Smith-Lemli-Opitz syndrome, especially with regard to genotype-phenotype correlation, we describe 5 Polish patients with mild phenotype (one with novel mutation in DHCR7 gene and four published before) and analyze 18 other cases from the literature. As the conclusion we give recommendation for tests toward SLOS in cases with "idiopathic" intellectual impairment and/or behavioral anomalies, as well as in biochemically doubtful but clinically fitting cases with overall gestalt and history of this syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18249054     DOI: 10.1016/j.ejmg.2007.11.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  5 in total

1.  Differences between predicted and established diagnoses of Smith-Lemli-Opitz syndrome in the Polish population: underdiagnosis or loss of affected fetuses?

Authors:  Aleksandra Jezela-Stanek; Elżbieta Ciara; Ewa Małunowicz; Krystyna Chrzanowska; Anna Latos-Bieleńska; Małgorzata Krajewska-Walasek
Journal:  J Inherit Metab Dis       Date:  2010-06-16       Impact factor: 4.982

2.  Adrenal function in Smith-Lemli-Opitz syndrome.

Authors:  Simona E Bianconi; Sandra K Conley; Meg F Keil; Ninet Sinaii; Kristina I Rother; Forbes D Porter; Constantine A Stratakis
Journal:  Am J Med Genet A       Date:  2011-10-11       Impact factor: 2.802

3.  Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome.

Authors:  Anna V Oláh; Gabriella P Szabó; József Varga; Lídia Balogh; Györgyi Csábi; Violetta Csákváry; Wolfgang Erwa; István Balogh
Journal:  Eur J Pediatr       Date:  2013-01-15       Impact factor: 3.183

Review 4.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

5.  Dhcr7 Regulates Palatal Shelf Fusion through Regulation of Shh and Bmp2 Expression.

Authors:  Wen-lin Xiao; Dai-zun Zhang; Hong Xu; Cui-zhu Zhuang
Journal:  Biomed Res Int       Date:  2016-03-15       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.